The Latest: India drugmaker to produce Sputnik V doses

NEW DELHI, India — Russia’s sovereign wealth fund announced a manufacturing deal with the Indian pharmaceutical maker Virchow Biotech Private Limited for making 200 million doses of the Sputnik V vaccine each year.

This is the fourth manufacturing deal announced by Russia, and 700 million doses of the Russian vaccine will now be made in India.

Last week, two manufacturing deals for the vaccine in India were announced: Gland Pharma Pvt Ltd., a subsidiary of Chinese pharmaceutical company Fosun Pharma, said Tuesday it would 252 million doses vaccine and Stelis Biopharma partnered to produce and supply 200 million doses of the vaccine. Earlier, a deal to make 100 million doses of the vaccine annually was announced by Indian pharmaceutical firm Hetero Biopharma.

India has been pledged 125 million doses of the vaccine by Russia.

___

THE VIRUS OUTBREAK:

— AstraZeneca: US data shows vaccine effective for all ages

— Germany looks set to extend lockdown measures again

— Taiwan gives health workers island’s first AstraZeneca doses

— Teachers lament ‘chaotic’ virus rules in German schools

___

Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak

___

HERE’S WHAT ELSE IS HAPPENING:

LONDON — AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease across all age groups in a late-stage study in the United States, the...